Scrivo, R., Diamanti, A. P., Chimenti, M. S., Molteni, E., Sciarra, G., Bari, F., … Conti, F. (2022). Secukinumab Treatment in Patients with Spondyloarthritis and Concomitant Demyelinating Disease: Rationale of IL-17 Inhibition and Clinical Outcome. Archives of Clinical and Medical Case Reports, 6(5), 660–668. Retrieved from https://fortunejournals.org/ojs/index.php/acmcr/article/view/22670